drugset / Trial / NCT03993366

Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

NCT03993366

RandomizedCrossoverOpen-labelTreatment

Summary

The aim of this pilot study is to generate preliminary data of (i) Fiasp-plus-Pramlintide closed-loop system with a simple meal announcement, compared to (ii) Fiasp-alone closed-loop system with full carbohydrate counting, in preparation for an outpatient study over two weeks

Timeline

Start
2019-03-01
Primary completion
2019-08-06
Completion
2019-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramlintide Peptide
Background insulin aspart Protein / enzyme biologic